Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

217-228 of 242 results
Page 19 of 21
Key Publications July 21, 2016

Cholesterol lowering in intermediate-risk persons without cardiovascular disease.

N Engl J Med. 2016;374:2021-31

Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P et al.
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications July 21, 2016

Blood-pressure and cholesterol lowering in persons without cardiovascular disease.

N Engl J Med. 2016;374:2032-43

Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J, Xavier D et al.
Clinical Trials Hypertension Lipids/Lipoproteins
Key Publications July 20, 2016

Blood-pressure lowering in intermediate-risk persons without cardiovascular disease.

N Engl J Med. 2016;374:2009-20

Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D et al.
Cardiovascular Disease Clinical Trials Hypertension
Key Publications June 22, 2016

The high-density lipoprotein puzzle: Why classic epidemiology, genetic epidemiology, and clinical trials conflict?

Arterioscler Thromb Vasc Biol. 2016;36:777-82

Rosenson RS
Clinical Trials Genetics Lipids/Lipoproteins
Key Publications May 20, 2016

A VOYAGER meta-analysis of the impact of statin therapy on low-density lipoprotein cholesterol and triglyceride levels in patients with hypertriglyceridemia.

Am J Cardiol. 2016;117:1444-8

Karlson BW, Palmer MK, Nicholls SJ, Lundman P, Barter PJ
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications May 18, 2016

Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study.

Eur Heart J. 2016;37:1079-81

Mozaffarian D
Cardiometabolic Risk Clinical Trials Nutrition
Key Publications May 18, 2016

A healthy nordic diet alters the plasma lipidomic profile in adults with features of metabolic syndrome in a multicenter randomized dietary intervention.

J Nutr. 2015;146:662-672

Ankinen M, Schwab U, Kolehmainen M, Paananen J, Nygren H, Seppänen-Laakso T et al.
Clinical Trials Lipids/Lipoproteins Metabolic Syndrome
Key Publications May 17, 2016

Population and assay thresholds for the predictive value of lipoprotein (a) for coronary artery disease: the EPIC-Norfolk Prospective Population Study.

J Lipid Res. 2016;57:697-705

Verbeek R, Boekholdt SM, Stoekenbroek RM, Hovingh GK, Witztum JL, Wareham NJ, Sandhu MS, Khaw KT, Tsimikas S
Acute Coronary Syndromes Clinical Trials Lipids/Lipoproteins
Key Publications May 17, 2016

Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study.

Eur Heart J. 2016;37:1072-8

Kleber ME, Delgado GE, Lorkowski S, März W, von Schacky C
Cardiovascular Disease Clinical Trials Lipids/Lipoproteins
Key Publications May 16, 2016

Effects of combined healthy lifestyle factors on functional vascular aging: the Rotterdam Study.

J Hypertens. 2016;34:853-9

Karimi L, Mattace-Raso FU, van Rosmalen J, van Rooij F, Hofman A, Franco OH
Cardiometabolic Risk Clinical Trials Nutrition
Key Publications April 13, 2016

Novel approaches in primary cardiovascular disease prevention: The HOPE-3 Trial rationale, design, and participants' baseline characteristics.

Can J Cardiol. 2016;32:311-8

Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A et al.
Cardiovascular Disease Clinical Trials Prevention
Key Publications April 12, 2016

Tribulations of recent cardiology trials, the Audacity of Hope, and HOPE-3.

Can J Cardiol. 2016;32:275-7

Waters DD, Chau KH
Cardiovascular Disease Clinical Trials Prevention
of 21